Liver Disease
Feature
AGA Clinical Practice Update: Expert review recommendations on post-SVR hepatitis C care
Attention should be paid to fibrosis, cirrhosis, esophagogastric varices, and factors that could contribute to liver injury or hepatic...
News
AGA Guideline: Transient elastography in liver fibrosis, most used and most accurate
Nonalcoholic fatty liver disease may be the weak spot for VCTE.
Conference Coverage
Norfloxacin improves short-term advanced cirrhosis survival
Infections at 6 and 12 months were secondary outcomes of a norfloxacin study and showed fewer infections overall.
From the Journals
Mortality rate was 10-fold higher in opioid use disorder patients
Individuals with opioid use disorder have a significantly higher mortality rate than the general population.
Conference Coverage
Long-term albumin shows survival benefit in decompensated cirrhosis
AMSTERDAM – The ANSWER study showed long-term albumin administration to patients with decompensated cirrhosis may be seen as a disease-modifying...
Conference Coverage
WHO report sets baseline for viral hepatitis elimination
AMSTERDAM – An estimated 328 million people worldwide were living with chronic hepatitis B or C virus infection in 2015 according to a new report...
Commentary
Letter from the Editor: Spring brings flowers and liver stories
This month's issue of GI & Hepatology News is "weighted" towards liver.
News
FDA approves Sovaldi, Harvoni for HCV in ages 12-plus
The Food and Drug Administration has approved the use of Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) for the treatment of...
Conference Coverage
Liver disease likely to become increasing indication for bariatric surgery
Bariatric surgery is effective for treatment of fatty liver disease, showing a 90% improvement in steatosis.
News
Eliminating hepatitis in the United States: A road map
A new report shows how deaths and new infections can be slashed, but some question whether the political will is there.